Back to YC Companies
Talus Bio
Summer 2021
Active
Discovering drugs that target the DNA regulome
16 people View on YC
Talus Bio at a glance
- Y Combinator batch
- Summer 2021
- Status
- Active
- Industry
- Healthcare
- Team size
- 16 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Talus Bio
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.
Tags:
Biotech
Genomics
Drug discovery